Cellebrite CEO sells 103K shares for RSU tax obligations

Cellebrite DI Ltd. Chief Executive Officer Thomas E. Hogan reported an open-market sale of 103,188 ordinary shares.

Rhea-AI Filing Summary

Cellebrite DI Ltd. Chief Executive Officer Thomas E. Hogan reported an open-market sale of 103,188 ordinary shares. The shares were originally granted as restricted stock units on September 19, 2025, and the disposition is associated with tax obligations arising from the RSU vesting.

The shares were sold at a weighted average price of $15.7566 per share, in multiple trades between $15.44 and $15.97. Following this transaction, Hogan directly holds 590,777 ordinary shares of Cellebrite DI Ltd.

Insider Trade Summary

Net Seller: 103,188 shares

Net Sell 1 txn

Insider Hogan Thomas E.

Role Chief Executive Officer

Sold 103,188 shs ($1.63M)

Type	Security	Shares	Price	Value
Sale	Ordinary shares, par value NIS 0.00001	103,188	$15.7566	$1.63M

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 590,777 shares (Direct)

Footnotes (2)

1. F1. The shares reported as disposed herein were granted on September 19, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 103,188 shares Weighted average sale price: $15.7566 per share Sale price range: $15.44–$15.97 per share +2 more

5 metrics

Shares sold 103,188 shares Ordinary shares sold on 2026-07-02

Weighted average sale price $15.7566 per share Open-market sale price, multiple trades

Sale price range $15.44–$15.97 per share Range of individual trade prices

Shares held after transaction 590,777 shares Direct holdings post-transaction

Grant date of RSUs September 19, 2025 RSUs underlying disposed shares

Key Terms

restricted stock units ("RSUs"), weighted average price, open-market sale, tax obligations

4 terms

restricted stock units ("RSUs") financial

"The shares reported as disposed herein were granted on September 19, 2025, in the form of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

tax obligations financial

"The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cellebrite (CLBT) CEO Thomas Hogan report in this Form 4 filing?

Cellebrite CEO Thomas Hogan reported an open-market sale of 103,188 ordinary shares. The sale relates to tax obligations from the vesting of previously granted restricted stock units, rather than a discretionary reduction of a long-held share position.

How many Cellebrite (CLBT) shares did the CEO sell and at what price?

Thomas Hogan sold 103,188 ordinary shares of Cellebrite at a weighted average price of $15.7566 per share. The transactions took place across multiple trades, with individual prices ranging from $15.44 to $15.97 per share, as disclosed.

Why were Thomas Hogan’s Cellebrite (CLBT) shares sold according to the Form 4 footnotes?

The shares were sold in connection with tax obligations arising from the vesting of restricted stock units granted on September 19, 2025. This means the disposition was primarily to satisfy tax liabilities tied to equity compensation, rather than an ordinary portfolio rebalancing.

How many Cellebrite (CLBT) shares does the CEO hold after this reported sale?

After the reported sale, Thomas Hogan directly holds 590,777 ordinary shares of Cellebrite DI Ltd. This post-transaction holding figure comes directly from the Form 4 and reflects his remaining direct equity stake following the tax-related disposition.

What price range did the Cellebrite (CLBT) CEO’s share sales cover?

The Form 4 notes that the CEO’s shares were sold in multiple transactions at prices ranging from $15.44 to $15.97 per share. The reported $15.7566 figure is the weighted average sale price across all these individual trades on the transaction date.

Were the disposed Cellebrite (CLBT) shares related to restricted stock units (RSUs)?

Yes. The Form 4 explains that the disposed shares were originally granted as restricted stock units on September 19, 2025. The sale is associated with tax obligations tied to the vesting of those RSUs, linking the transaction directly to equity compensation events.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 07:29 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hogan Thomas E.

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	07/02/2026		S		103,188(1)	D	$15.7566(2)	590,777	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported as disposed herein were granted on September 19, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.44 to $15.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Thomas E. Hogan	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)